Abstract
An evaluation was made of a fully automated index of psoriasis, termed Computer-assisted Area and Severity Index (CASI). This method requires taking digital photographs of the target skin area(s) with a colour reference marker, Casmatch®. The CASI evaluates the severity of the psoriasis from the size and redness of the lesion(s). In five patients with mild psoriasis vulgaris mainly observed on their trunk, 18 photographs of the trunk were taken every 2 weeks. Three of the five patients [Psoriasis Area and Severity Index (PASI) of 3.0, 3.6 and 10.1, respectively] were treated with oral ciclosporin 3 mg/kg/day for 4 weeks. The mean ± SD area of lesion selected by a dermatologist was 2.3 ± 1.3% of the total skin area. This method achieved extraction performance for psoriasis of 72.1 ± 19.4% for sensitivity and 97.4 ± 2.0% for specificity. CASI correlated strongly with PASI (r = 0.92), but not with Skindex16® (r = 0.35). Although only erythema was evaluated, our preliminary results indicate that this method is capable of quantifying psoriasis lesions.
| Original language | English |
|---|---|
| Pages (from-to) | 830-833 |
| Number of pages | 4 |
| Journal | Clinical and Experimental Dermatology |
| Volume | 34 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2009 Oct |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Computerized quantification of psoriasis lesions with colour calibration : Preliminary results. / Iyatomi, H.; Oka, H.; Hagiwara, Masafumi; Miyake, A.; Kimoto, M.; Ogawa, K.; Tanaka, M.
In: Clinical and Experimental Dermatology, Vol. 34, No. 7, 10.2009, p. 830-833.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Computerized quantification of psoriasis lesions with colour calibration
T2 - Preliminary results
AU - Iyatomi, H.
AU - Oka, H.
AU - Hagiwara, Masafumi
AU - Miyake, A.
AU - Kimoto, M.
AU - Ogawa, K.
AU - Tanaka, M.
PY - 2009/10
Y1 - 2009/10
N2 - An evaluation was made of a fully automated index of psoriasis, termed Computer-assisted Area and Severity Index (CASI). This method requires taking digital photographs of the target skin area(s) with a colour reference marker, Casmatch®. The CASI evaluates the severity of the psoriasis from the size and redness of the lesion(s). In five patients with mild psoriasis vulgaris mainly observed on their trunk, 18 photographs of the trunk were taken every 2 weeks. Three of the five patients [Psoriasis Area and Severity Index (PASI) of 3.0, 3.6 and 10.1, respectively] were treated with oral ciclosporin 3 mg/kg/day for 4 weeks. The mean ± SD area of lesion selected by a dermatologist was 2.3 ± 1.3% of the total skin area. This method achieved extraction performance for psoriasis of 72.1 ± 19.4% for sensitivity and 97.4 ± 2.0% for specificity. CASI correlated strongly with PASI (r = 0.92), but not with Skindex16® (r = 0.35). Although only erythema was evaluated, our preliminary results indicate that this method is capable of quantifying psoriasis lesions.
AB - An evaluation was made of a fully automated index of psoriasis, termed Computer-assisted Area and Severity Index (CASI). This method requires taking digital photographs of the target skin area(s) with a colour reference marker, Casmatch®. The CASI evaluates the severity of the psoriasis from the size and redness of the lesion(s). In five patients with mild psoriasis vulgaris mainly observed on their trunk, 18 photographs of the trunk were taken every 2 weeks. Three of the five patients [Psoriasis Area and Severity Index (PASI) of 3.0, 3.6 and 10.1, respectively] were treated with oral ciclosporin 3 mg/kg/day for 4 weeks. The mean ± SD area of lesion selected by a dermatologist was 2.3 ± 1.3% of the total skin area. This method achieved extraction performance for psoriasis of 72.1 ± 19.4% for sensitivity and 97.4 ± 2.0% for specificity. CASI correlated strongly with PASI (r = 0.92), but not with Skindex16® (r = 0.35). Although only erythema was evaluated, our preliminary results indicate that this method is capable of quantifying psoriasis lesions.
UR - http://www.scopus.com/inward/record.url?scp=70349492498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349492498&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2230.2008.03169.x
DO - 10.1111/j.1365-2230.2008.03169.x
M3 - Article
C2 - 19438532
AN - SCOPUS:70349492498
VL - 34
SP - 830
EP - 833
JO - Clinical and Experimental Dermatology
JF - Clinical and Experimental Dermatology
SN - 0307-6938
IS - 7
ER -